Table 3 Epidemiological features of imported microscopic malaria and SMM
Epidemiological features by group | |||||
|---|---|---|---|---|---|
Microscopic malaria | Submicroscopic malaria | p value | |||
Age. Mean (SD) | 39 (13.9) | 40 (15.2) | 0.527 | ||
Male sex. N (%) | 104 (55%) | 51 (49%) | 0.326 | ||
Group. N (%) | |||||
Traveller (not immune) | 54 (28.6%) | 13 (12.5%) | < 0.001 | ||
Semiimmune | 135 (71.4%) | 91 (87.5%) | |||
Native | 55 (29.1%) | 83 (79.8%) | |||
Resident in endemic zone | 12 (6.3%) | 2 (1.9%) | |||
Native-traveller | 68 (36%) | 6 (5.8%) | |||
Prophylaxis. N (%) | 30 (15.9%) | 6 (5.8%) | 0.012 | ||
Drug | |||||
Atovaquone-proguanil | 3 (1.6%) | 4 (3.8%) | |||
Doxycycline | 3 (1.6%) | 0 | |||
Mefloquine | 15 (7.9%) | 0 | |||
Others | 9(4.8%) | 2 (2%) | |||
Comorbidity. N (%) | 102 (54%) | 75 (72.1%) | 0.002 | ||
Parasitological infection | 25 (24.5%) | 55 (73.3%) | < 0.001 | ||
Filariae | 11 (10.8%) | 36 (48%) | < 0.001 | ||
Intestinal helmints | 11 (10.8%) | 26 (34.7%) | < 0.001 | ||
Others | 16 (15.2%) | 30 (40%) | < 0.001 | ||
HIV | 16 (15.8%) | 11 (14.7%) | 0.831 | ||
HBV | 15 (7.9%) | 7 (6.7%) | 0.708 | ||
HCV | 14 (7.4%) | 9 (8.6%) | 0.294 | ||
Number of different countries of acquisition | 31 (Equatorial Guinea 69.3% (114); Nigeria 5.3% (10); Cameroon 3.7% (7); Mali 3.2% (6))* | 15 (Equatorial Guinea 81.7% (85); Cameroon 2.9% (3))* | n.a. | ||